Safety Follow-up of a Randomized, Vehicle-Controlled, Multicenter, Double-Masked Phase 3 Trial with Lotilaner Ophthalmic Solution, 0.25% for Treatment of Demodex Blepharitis
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined